Neil E Simister

Title: Neil E Simister: Innovator in Transepithelial Therapeutics

Introduction

Neil E Simister is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of therapeutics, particularly in the area of transepithelial transport. With a total of 6 patents to his name, Simister's work focuses on innovative methods for delivering therapeutics and initiating immune responses.

Latest Patents

Simister's latest patents include groundbreaking inventions related to receptor-specific transepithelial transport of therapeutics. These inventions detail methods and products for initiating an immune response against antigens. They specifically address transepithelial delivery of antigens to provoke tolerance and immunity. The patents also cover the delivery of therapeutics conjugated to an FcRn binding partner to various epithelial tissues, including intestinal and mucosal epithelium, as well as the epithelium of the lung. Furthermore, the inventions encompass the synthesis, preparation, and use of FcRn binding partner conjugates in pharmaceutical compositions for oral systemic delivery of drugs and vaccines.

Career Highlights

Throughout his career, Neil E Simister has worked with esteemed institutions such as Brigham and Women's Hospital, Inc. and Brandeis University. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Simister has collaborated with notable colleagues, including Richard S Blumberg and Wayne I Lencer. These collaborations have further enriched his research and innovations in the field of therapeutics.

Conclusion

Neil E Simister is a distinguished inventor whose work in transepithelial therapeutics has the potential to revolutionize drug delivery and immune response strategies. His contributions continue to impact the field positively.